BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 25883389)

  • 1. The T-Cell Inhibitory Molecule Butyrophilin-Like 2 Is Up-regulated in Mild Plasmodium falciparum Infection and Is Protective During Experimental Cerebral Malaria.
    Subramaniam KS; Spaulding E; Ivan E; Mutimura E; Kim RS; Liu X; Dong C; Feintuch CM; Zhang X; Anastos K; Lauvau G; Daily JP
    J Infect Dis; 2015 Oct; 212(8):1322-31. PubMed ID: 25883389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malaria-specific and nonspecific activation of CD8+ T cells during blood stage of Plasmodium berghei infection.
    Miyakoda M; Kimura D; Yuda M; Chinzei Y; Shibata Y; Honma K; Yui K
    J Immunol; 2008 Jul; 181(2):1420-8. PubMed ID: 18606696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA.
    Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF
    Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology.
    Hafalla JC; Claser C; Couper KN; Grau GE; Renia L; de Souza JB; Riley EM
    PLoS Pathog; 2012 Feb; 8(2):e1002504. PubMed ID: 22319445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Virus Hosted in Malaria-Infected Blood Protects against T Cell-Mediated Inflammatory Diseases by Impairing DC Function in a Type I IFN-Dependent Manner.
    Hassan A; Wlodarczyk MF; Benamar M; Bassot E; Salvioni A; Kassem S; Berry A; Saoudi A; Blanchard N
    mBio; 2020 Apr; 11(2):. PubMed ID: 32265335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection-Induced Resistance to Experimental Cerebral Malaria Is Dependent Upon Secreted Antibody-Mediated Inhibition of Pathogenic CD8
    Shaw TN; Inkson CA; Villegas-Mendez A; Pattinson DJ; Strangward P; Else KJ; Draper SJ; Zeef LAH; Couper KN
    Front Immunol; 2019; 10():248. PubMed ID: 30846985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase C θ deficiency increases resistance of C57BL/6J mice to Plasmodium berghei infection-induced cerebral malaria.
    Ohayon A; Golenser J; Sinay R; Tamir A; Altman A; Pollack Y; Isakov N
    Infect Immun; 2010 Oct; 78(10):4195-205. PubMed ID: 20660606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria.
    Oakley MS; Sahu BR; Lotspeich-Cole L; Solanki NR; Majam V; Pham PT; Banerjee R; Kozakai Y; Derrick SC; Kumar S; Morris SL
    J Immunol; 2013 Nov; 191(9):4699-708. PubMed ID: 24078698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii.
    Keswani T; Bhattacharyya A
    Exp Parasitol; 2014 Jun; 141():82-92. PubMed ID: 24675415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory responses associated with the induction of cerebral malaria: lessons from experimental murine models.
    Hansen DS
    PLoS Pathog; 2012 Dec; 8(12):e1003045. PubMed ID: 23300435
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of CD8
    Barrera V; Haley MJ; Strangward P; Attree E; Kamiza S; Seydel KB; Taylor TE; Milner DA; Craig AG; Couper KN
    Front Immunol; 2019; 10():1747. PubMed ID: 31396236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation.
    Nguyen T; Liu XK; Zhang Y; Dong C
    J Immunol; 2006 Jun; 176(12):7354-60. PubMed ID: 16751379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4(+) T Cell Immunity.
    Karunarathne DS; Horne-Debets JM; Huang JX; Faleiro R; Leow CY; Amante F; Watkins TS; Miles JJ; Dwyer PJ; Stacey KJ; Yarski M; Poh CM; Lee JS; Cooper MA; Rénia L; Richard D; McCarthy JS; Sharpe AH; Wykes MN
    Immunity; 2016 Aug; 45(2):333-45. PubMed ID: 27533014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selected P. falciparum specific immune responses are maintained in AIDS adults in Burkina Faso.
    Migot F; Ouedraogo JB; Diallo J; Zampan H; Dubois B; Scott-Finnigan T; Sanou PT; Deloron P
    Parasite Immunol; 1996 Jul; 18(7):333-9. PubMed ID: 9229386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host Resistance to Plasmodium-Induced Acute Immune Pathology Is Regulated by Interleukin-10 Receptor Signaling.
    Claser C; De Souza JB; Thorburn SG; Grau GE; Riley EM; Rénia L; Hafalla JCR
    Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28396319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of crude Plasmodium falciparum antigens for comparison of antibody responses in patients with mild malaria vs. cerebral malaria.
    Mbengue B; Niang B; Diatta B; Tall A; Garraud O; Perraut R; Dieye A
    Iran J Immunol; 2010 Sep; 7(3):150-61. PubMed ID: 20876986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased survival in B-cell-deficient mice during experimental cerebral malaria suggests a role for circulating immune complexes.
    de Oliveira RB; Wang JP; Ram S; Gazzinelli RT; Finberg RW; Golenbock DT
    mBio; 2014 Mar; 5(2):e00949-14. PubMed ID: 24643866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malaria.
    Guo J; McQuillan JA; Yau B; Tullo GS; Long CA; Bertolino P; Roediger B; Weninger W; Taylor GA; Hunt NH; Ball HJ; Mitchell AJ
    Infect Immun; 2015 Apr; 83(4):1406-17. PubMed ID: 25644000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild Plasmodium falciparum malaria following an episode of severe malaria is associated with induction of the interferon pathway in Malawian children.
    Krupka M; Seydel K; Feintuch CM; Yee K; Kim R; Lin CY; Calder RB; Petersen C; Taylor T; Daily J
    Infect Immun; 2012 Mar; 80(3):1150-5. PubMed ID: 22232187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation.
    Arnett HA; Escobar SS; Gonzalez-Suarez E; Budelsky AL; Steffen LA; Boiani N; Zhang M; Siu G; Brewer AW; Viney JL
    J Immunol; 2007 Feb; 178(3):1523-33. PubMed ID: 17237401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.